PI Industries Share Price, Fundamentals and Financials
Track the live share price, 52 week range, interactive chart, financial highlights, shareholding, ratios, peers and corporate actions.
Track the live share price, 52 week range, interactive chart, financial highlights, shareholding, ratios, peers and corporate actions.
Switch between 1 Day, 5 Day, 1 Month and 1 Year views.
PI Industries Limited is an Indian agrisciences and life-sciences company with capabilities spanning discovery, process research, product development, commercial manufacturing and branded crop solutions. It serves Indian agriculture through domestic products and supports global innovators through custom synthesis and manufacturing relationships.
For farmers and channel partners, product suitability, authorised use, label compliance and safe handling are important. For investors, the custom synthesis pipeline, new product launches, capacity utilisation, margins, working capital, capital expenditure and regulatory compliance are key monitorables.
PI Industries operates across domestic agri-brands, custom synthesis and manufacturing, research and development, biologicals and selected health-sciences activities. Its custom synthesis operations develop and manufacture complex molecules for global customers, while the domestic business markets crop-protection and farm-productivity solutions in India.
Verify the latest segment revenue, customer mix, product pipeline and capacity details from the company’s investor presentation and exchange filings.
PIIND mainly earns fees for managing construction projects and revenue from EPC execution. In PMC assignments, it coordinates planning, tendering, supervision and delivery for clients. In EPC projects, it assumes wider execution responsibility. It also develops or monetises real estate in selected projects. Revenue visibility depends on the order book, while actual earnings depend on execution pace, margins, collections and working-capital discipline.
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Revenue from Operations | ₹7,665 Cr | ₹8,346 Cr | ₹8,454 Cr |
| Operating Profit | ₹2,030 Cr | ₹2,350 Cr | ₹2,420 Cr |
| Operating Margin | 26% | 28% | 29% |
| Other Income | ₹354 Cr | ₹421 Cr | ₹455 Cr |
| Profit Before Tax | ₹2,146 Cr | ₹2,481 Cr | ₹2,552 Cr |
| Net Profit | ₹1,681 Cr | ₹1,932 Cr | ₹1,990 Cr |
| EPS | ₹110.77 | ₹127.31 | ₹131.10 |
| Dividend Payout | 14% | 13% | 12% |
Verify the latest audited or reviewed financial results from company and exchange filings.
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity Capital | ₹15 Cr | ₹15 Cr | ₹15 Cr |
| Reserves | ₹8,708 Cr | ₹10,118 Cr | ₹11,480 Cr |
| Borrowings | ₹477 Cr | ₹573 Cr | ₹625 Cr |
| Other Liabilities | ₹2,330 Cr | ₹2,778 Cr | ₹3,070 Cr |
| Total Liabilities | ₹11,530 Cr | ₹13,484 Cr | ₹15,190 Cr |
| Fixed Assets | ₹4,061 Cr | ₹4,704 Cr | ₹5,295 Cr |
| Investments | ₹2,099 Cr | ₹2,376 Cr | ₹2,625 Cr |
| Other Assets | ₹5,370 Cr | ₹6,404 Cr | ₹7,270 Cr |
| Total Assets | ₹11,530 Cr | ₹13,484 Cr | ₹15,190 Cr |
Verify debt, assets, liabilities and contingent liabilities from the latest official filing.
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Operating Cash Flow | ₹1,253 Cr | ₹1,490 Cr | ₹1,560 Cr |
| Investing Cash Flow | -₹1,186 Cr | -₹1,329 Cr | -₹1,410 Cr |
| Financing Cash Flow | -₹322 Cr | -₹394 Cr | -₹405 Cr |
| Net Cash Flow | -₹255 Cr | -₹233 Cr | -₹255 Cr |
| Capital Expenditure | ₹744 Cr | ₹862 Cr | ₹930 Cr |
| Free Cash Flow | ₹509 Cr | ₹628 Cr | ₹630 Cr |
Real estate cash flow can vary with launches, collections, construction and land payments.
| Metric | Long-term | Medium-term | Recent |
|---|---|---|---|
| ROE | 10Y: 18% | 5Y: 19% | Latest year: 18% |
| ROCE | Mar 2024: 22% | Mar 2025: 21% | Mar 2026: 20% |
| Sales Growth | 10Y: 15% | 5Y: 14% | 3Y: 11% |
| Profit Growth | 10Y: 21% | 5Y: 24% | 3Y: 18% |
| Stock Price CAGR | 5Y: 9% | 3Y: -2% | 1Y: -18% |
| Working Capital Days | Mar 2024: 149 | Mar 2025: 171 | Mar 2026: 185 |
| Company | Business Focus | Comparison Monitorable |
|---|---|---|
| PI Industries Ltd | Agrisciences, CSM and life sciences | CSM pipeline, product mix, margins and working capital |
| UPL Ltd | Global crop protection and seeds | Leverage, global demand and operating margins |
| Bayer CropScience Ltd | Crop protection, seeds and farm solutions | Domestic demand, product portfolio and dividends |
| Sumitomo Chemical India Ltd | Crop protection and household insecticides | Volume growth, margins and product launches |
| Rallis India Ltd | Crop care, seeds and contract manufacturing | Domestic demand, exports and margin recovery |
| Year | Dividend Detail | Note |
|---|---|---|
| FY 2025-26 | ₹5 interim dividend | Ex-date reported as 23 Feb 2026 |
| FY 2024-25 | ₹10 final and ₹6 interim dividend | Verify record dates and payment details from exchange filings |
| FY 2023-24 | ₹9 final and ₹6 interim dividend | Verify the latest corporate-action history on NSE/BSE |
| Action | Detail | Note |
|---|---|---|
| Bonus Issue | 1:2 bonus in 2010 | Last reported bonus ex-date was 8 Jul 2010 |
| Earlier Bonus | 1:1 bonus in 2009 | Verify historical entitlement from official records |
| Stock Split | Face value changed to ₹1 | Latest split history should be verified on NSE/BSE |
Verify the latest dividend, record date, bonus, split and face-value details from PI Industries, NSE or BSE filings.
PI Industries is an Indian agrisciences and life-sciences company. It develops, manufactures and markets crop-protection products and provides custom synthesis and manufacturing services to global innovators.
The NSE symbol is PIIND, the BSE code is 523642 and the Yahoo Finance-compatible symbol is PIIND.NS.
Its activities include domestic agri-brands, custom synthesis and manufacturing, biologicals, research and development, and selected health-sciences or pharmaceutical services.
Under custom synthesis and manufacturing, PI develops and manufactures proprietary molecules or intermediates for global customers under long-term relationships and confidentiality arrangements.
Customers include Indian farmers and distributors for domestic agri-products, as well as global crop-science, specialty-chemical and life-sciences innovators for custom manufacturing.
It earns from domestic branded crop-protection products and from research, process development and commercial manufacturing for global customers. Revenue depends on product demand, customer pipelines, capacity utilisation and currency movements.
Farmers should use only authorised products, follow the approved crop and dosage label, wear protective equipment and obtain advice from qualified agricultural professionals.
Important monitorables include CSM order visibility, new molecule commercialisation, domestic agri demand, capacity utilisation, capital expenditure, margins, working capital, customer concentration and regulatory approvals.
Risks include agrochemical regulation, customer concentration, delayed molecule launches, raw-material volatility, currency movements, environmental compliance, weather-dependent farm demand and execution of new life-sciences investments.
PI Industries has paid interim and final dividends, but future payouts depend on profitability, cash flow, capital expenditure and board approval.
The company has historical bonus issues, including 1:2 in 2010 and 1:1 in 2009. Investors should verify current face value and full corporate-action history on official exchanges.
Compare growth, operating margin, return ratios, CSM pipeline, domestic product strength, research capability, capital intensity, working capital and valuation.
No. This page is educational and does not provide a buy or sell recommendation.